Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
16.5K
-
Shares change
-
-31.6K
-
Total reported value, excl. options
-
$151K
-
Value change
-
-$190K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$9.20
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q4 2023
2 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5K shares
of 86.3M outstanding shares and own 0.02% of the company stock.
Largest 10 shareholders include FMR LLC (7M shares), Nextech Invest Ltd. (4.29M shares), ALKEON CAPITAL MANAGEMENT LLC (3.6M shares), Column Group LLC (3.57M shares), EcoR1 Capital, LLC (3.42M shares), BlackRock Inc. (3.1M shares), VR Adviser, LLC (2.43M shares), VANGUARD GROUP INC (2.25M shares), Frazier Life Sciences Management, L.P. (2.14M shares), and ArrowMark Colorado Holdings LLC (1.73M shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.